Cell-penetrating peptides TAT and 8R both significantly enhanced cellular uptake and tissue retention of P22 virus-like particles in vivo, with TAT showing preferential accumulation in lungs and 8R in brain at 24 hours post-injection.
Tissue-specific targetingTAT-VLPs accumulated preferentially in lungs while 8R-VLPs showed better brain accumulation at 24 hours, demonstrating that CPP choice can direct tissue targeting
What the researchers found
Both TAT and 8R CPPs significantly enhanced P22 VLP cellular uptake in vitro and tissue accumulation in vivo. At 24 hours post-injection, TAT-conjugated VLPs showed superior lung distribution and retention, while 8R-conjugated VLPs showed better brain accumulation. TAT was overall superior for cellular uptake and tissue accumulation.
Why it matters
Targeted drug delivery remains a major challenge in medicine. This study demonstrates that different cell-penetrating peptides can direct the same nanoparticle platform to different tissues — TAT to lungs, 8R to brain — opening possibilities for tissue-specific drug delivery using a modular peptide-based targeting approach.
The numbers in context
Two CPPs tested: TAT and 8R. P22 VLP platform used as delivery vehicle. Tissue-specific distribution patterns observed.
How the study worked
In vitro and in vivo study: P22 VLP self-assembled particles prepared using a prokaryotic expression system with TAT- or 8R-conjugated mCherry on the capsid protein. Cellular uptake measured by fluorescence in vitro. Tissue distribution and retention assessed in animal models at multiple time points post-injection.
Who was studied
Animal models for tissue distribution studies
What this study cannot tell us
Animal study with no human data. Tissue distribution was assessed using fluorescent reporter, not actual therapeutic cargo. Long-term retention and potential immunogenicity of VLP-CPP constructs not evaluated. The mechanism underlying differential tissue targeting of TAT vs 8R is not fully explained.
How to read the evidence
Rated preliminary: animal study demonstrating proof-of-concept for CPP-mediated tissue targeting. No therapeutic payload delivery or human data.
When this study was published
Published in 2024. Represents current advances in peptide-functionalized nanoparticle delivery systems.
The bigger picture
Virus-like particles are emerging as versatile delivery vehicles for drugs, vaccines, and imaging agents. Adding cell-penetrating peptides with tissue-specific homing properties could transform VLPs from passive carriers into actively targeted delivery systems, particularly valuable for lung diseases and neurological conditions.
Questions still open
- What drives the tissue-specific accumulation differences between TAT (lungs) and 8R (brain)?
- Can the brain-targeting 8R-VLP platform cross the blood-brain barrier effectively enough for CNS drug delivery?
- How does the immune system respond to repeated administration of CPP-functionalized VLPs?
Common questions
What are virus-like particles and how are they used for drug delivery?
Can cell-penetrating peptides target drugs to specific organs?
Read the original research
Cell-penetrating peptides TAT and 8R functionalize P22 virus-like particles to enhance tissue distribution and retention in vivo.
Frontiers in veterinary science, 11, 1460973
Citation
Su, Shibo; Shen, Xuegang; Shi, Xinqi; Li, Xin; Chen, Jin; Yang, Wei; Sun, Mingxia; Tang, Yan-Dong; Wang, Haiwei; Wang, Shujie; Cai, Xuehui; Lu, Yu; An, Tongqing; Yang, Yongbo; Meng, Fandan. (2024). Cell-penetrating peptides TAT and 8R functionalize P22 virus-like particles to enhance tissue distribution and retention in vivo.. Frontiers in veterinary science, 11, 1460973. https://doi.org/10.3389/fvets.2024.1460973